NCT02738268

Laser Therapy for the Prevention of Radiodermatitis in Head and Neck Patients

Low-level Laser Therapy as a Tool for the Prevention of Radiodermatitis in Head and Neck Cancer Patients

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 46 (actual)
• Sponsor: Hasselt University · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

Up to 90% of the radiotherapy patients will develop a certain degree of skin reaction at the treated area, also known as radiodermatitis (RD). Currently, there is a wide variety of strategies to manage RD, including creams, gels, ointments, wound dressings. However, up to now, there is still no comprehensive, evidence-based consensus for the treatment of RD. Low-level laser therapy (LLLT) is a promising, non-invasive technique for treating RD. In a recent study conducted in our research group, LLLT prevented the aggravation of RD and provided symptomatic relief in patients undergoing radiotherapy for breast cancer after breast-sparing surgery. This was the first prospective study investigating the potential of LLLT for RD. In the current study, we want to investigate the efficacy of LLLT as a tool for the prevention of radiodermatitis in head and neck cancer patients.

Conditions

• Head Cancer
• Neck Cancer

Interventions

Type	Name	Description
DEVICE	Low-level laser therapy	Low-Level Laser Therapy will be applied, twice a week, from the start of radiotherapy treatment in combination with the standard skin care.
DEVICE	sham laser

Timeline

• Start date: 2016-01-01
• Primary completion: 2020-02-01
• Completion: 2020-02-01
• First posted: 2016-04-14
• Last updated: 2021-09-08

Locations

2 sites across 1 country: Belgium